Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
RE/MAX Holdings
RMAX
$265M
| $40M | 0.03% |
1,271,900
-1,300
| -0.1% | -$34.5K |
|
502
National Health Investors
NHI
$3.5B
| $39.8M | 0.03% |
656,000
-362,200
| -36% | -$19.9M |
|
503
FTI Consulting
FCN
$4.24B
| $39.7M | 0.03% |
346,749
+114,674
| +49% | +$13.9M |
|
|
GNMK
504
DELISTED
GenMark Diagnostics, Inc
GNMK
| $39.3M | 0.03% |
2,673,500
+2,092,200
| +360% | +$21.3M |
|
|
PXD
505
DELISTED
Pioneer Natural Resource Co.
PXD
| $39M | 0.03% |
399,488
+124,321
| +45% | +$11M |
|
506
DNOW Inc
DNOW
$2.95B
| $38.9M | 0.03% |
4,507,508
+1,357,984
| +43% | +$9.33M |
|
507
Cirrus Logic
CRUS
$6.08B
| $38.8M | 0.03% |
628,020
+57,562
| +10% | +$3.93M |
|
|
MRO
508
DELISTED
Marathon Oil Corporation
MRO
| $38.7M | 0.03% |
6,320,421
+2,913,075
| +85% | +$16.1M |
|
|
SAND
509
DELISTED
Sandstorm Gold
SAND
| $38.5M | 0.03% |
4,001,200
+562,300
| +16% | +$4.41M |
|
510
Stewart Information Services
STC
$2.07B
| $38.3M | 0.03% |
1,179,097
+43,400
| +4% | +$1.31M |
|
511
ATN International
ATNI
$491M
| $38.3M | 0.03% |
631,600
-9,300
| -1% | -$558K |
|
512
Supernus Pharmaceuticals
SUPN
$2.74B
| $37.8M | 0.03% |
1,592,800
+690,600
| +77% | +$15.3M |
|
513
Brookdale Senior Living
BKD
$3B
| $37.6M | 0.03% |
12,760,002
-529,200
| -4% | -$1.71M |
|
|
ENIA
514
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $37.6M | 0.03% |
5,006,400
-835,600
| -14% | -$6.48M |
|
515
J&J Snack Foods
JJSF
$1.7B
| $37.6M | 0.03% |
295,400
-35,050
| -11% | -$4.4M |
|
516
CMS Energy
CMS
$22.1B
| $37.5M | 0.03% |
642,494
-1,115,121
| -63% | -$64.6M |
|
517
McKesson
MCK
$99.9B
| $37.5M | 0.03% |
244,214
+110,888
| +83% | +$16M |
|
518
American Public Education
APEI
$828M
| $37.5M | 0.03% |
1,265,693
+63,300
| +5% | +$1.77M |
|
519
Extra Space Storage
EXR
$31.6B
| $37.4M | 0.03% |
405,336
-38,500
| -9% | -$3.58M |
|
520
Genmab
GMAB
$19.3B
| $37.4M | 0.03% |
1,103,097
+954,697
| +643% | +$26M |
|
521
Zebra Technologies
ZBRA
$18B
| $37.1M | 0.03% |
145,041
+55,310
| +62% | +$13M |
|
|
CVGW
522
DELISTED
Calavo Growers
CVGW
| $37.1M | 0.03% |
589,820
+73,700
| +14% | +$4.42M |
|
523
Sunstone Hotel Investors
SHO
$2.02B
| $37.1M | 0.03% |
4,552,431
-1,449,800
| -24% | -$12.6M |
|
524
Orion
OEC
$360M
| $37.1M | 0.03% |
3,500,296
-673,324
| -16% | -$6.22M |
|
525
Reinsurance Group of America
RGA
$16.4B
| $37M | 0.03% |
472,300
+142,800
| +43% | +$13.2M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.